Form 4: Tenet Healthcare CEO Sutaria Reports Equity Transactions

Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside new RSU grants.

Summary

• Saumya Sutaria, CEO and Director of Tenet Healthcare Corp (THC), reported multiple equity transactions on February 27, 2026.
• Transactions included the vesting of restricted stock units (RSUs) and performance share units (PSUs), leading to the acquisition of common stock.
• A total of 22,417 shares and 36,384 shares of common stock were acquired through the conversion of RSUs.
• To satisfy tax withholding obligations upon vesting, Sutaria disposed of 9,282 shares at $237.58 per share, 29,919 shares at $239.39 per share, and 124,959 shares at $239.39 per share.
• Sutaria also received a new grant of 36,092 time-based restricted stock units (2026 February RSUs).
• Following these transactions, Sutaria directly beneficially owns 533,564 shares of common stock.
• Additionally, Sutaria holds 36,092 2026 February Restricted Stock Units and 22,417 2024 February Restricted Stock Units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing. While there are significant share dispositions for tax purposes, these are offset by the vesting of substantial equity awards and a new RSU grant, indicating continued executive alignment and compensation.

Positives

• The CEO received a new grant of 36,092 restricted stock units, indicating continued long-term incentive alignment with company performance.
• The vesting of previously granted restricted stock units and performance share units demonstrates the realization of long-term compensation for the CEO.

Negatives

• A significant number of shares, totaling 164,160 shares, were disposed of to cover tax obligations, which reduces the CEO's direct common stock holdings.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

StockSavvy.ai notes that executive equity transactions, particularly those related to RSU vesting and tax withholding, are standard occurrences in the healthcare industry for publicly traded companies like Tenet Healthcare. These filings provide transparency into executive compensation structures and share ownership, which is a common practice across the sector.

Comparison to Industry Standards

• Executive compensation structures involving restricted stock units and performance share units with vesting schedules are standard practice across major U.S. healthcare providers.
• Similar equity compensation plans are observed at competitors like HCA Healthcare (HCA) and Universal Health Services (UHS), where executives also report periodic vesting and tax-related share dispositions.
• The reported transactions align with typical executive incentive programs designed to align management interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and share ownership, which can influence investor confidence. The disposition of shares for tax purposes is a common event and does not necessarily signal a lack of confidence.
• Employees: No direct impact on general employees is indicated.
• Management: The vesting and new grant of equity awards serve as a key component of the CEO's compensation and long-term incentive structure.

Next Steps

• The 2026 February Restricted Stock Units will vest in one-third increments on the first, second, and third anniversaries of the grant date.
• The remaining 2024 February Restricted Stock Units will vest in one-third increments on their anniversaries.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation transactions, including the vesting of equity awards and subsequent share dispositions for tax purposes, along with a new RSU grant. These are standard occurrences and do not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. The transactions reflect ongoing executive incentive alignment rather than a significant shift in insider sentiment or company prospects, thus a 'hold' recommendation is appropriate.

Keywords

Tenet Healthcare, THC, Saumya Sutaria, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Performance Share Units, Executive Compensation, Share Disposition, Tax Withholding, Healthcare Stock